Abstract:(Cell Stem Cell 4, 16–19; January 9, 2009) In our recent article, we unfortunately misquoted the findings in a recent study by Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar. When describing previous work using combination of the MEK inhibitor PD0325901 and the GSK3b inhibitor CHIR99021, our statement “Recent studies demonstrated that addition of the FGFR inhibitor PD173074 to the above cocktail is sufficient to maintain mESC pluripotency in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar).” was not accurate. Ying et al., in fact, used PD0325901 to replace PD1730474 and demonstrated maintenance of mESCs in the absence of LIF with these two factors only. The corrected section reads “Indeed, after serial passages, the growth of putative riPSCs treated with only PD0325901 and CHIR99021 declined, and the culture deteriorated due to the expansion of differentiated cells, although recent studies demonstrated that this combination of inhibitors can be used to maintain mESC self-renewal in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar). Because the TGFβ/Activin A/Nodal signaling cascade is essential to maintain undifferentiated hESCs and EpiSCs, but dispensable for mESC self-renewal, we tested whether the addition of an inhibitor of the type 1 TGFβ receptor, ALK5 (A-83-01), could help stabilize our riPSC cultures.” In addition, we omitted to mention that while our study was under review, Silva et al., 2008Silva J. Barrandon O. Nichols J. Kawaguchi J. Theunissen T.W. Smith A. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition.PLoS Biol. 2008; 6: 2237-2247https://doi.org/10.1371/journal.pbio.0060253Crossref Scopus (651) Google Scholar also published the use of these two inhibitors in the generation and propagation of mouse iPSCs. We apologize for any confusion caused. Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsLi et al.Cell Stem CellDecember 18, 2008In BriefConventional mouse and human embryonic stem cells (ESCs) can be typically derived by in vitro culture of blastocysts (Martin, 1981; Thomson et al., 1998), and induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells using defined genetic transduction methods (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). In both cases, different signaling pathways appear to regulate pluripotency with different characteristics in the two species. However, while rat ESC-like cells have been established based on certain traits (Demers et al., 2007; Ruhnke et al., 2003; Schulze et al., 2006; Ueda et al., 2008), to date, these lines fall short of exhibiting true pluripotency (e.g., fail to form teratoma or no/little contribution to chimerism) and thus cannot be considered authentic rat ESCs. Full-Text PDF Open Archive

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

The SIRT6 Activator MDL‐800 Improves Genomic Stability and Pluripotency of Old Murine‐derived Ips Cells

An Elaborate Regulation of Mammalian Target of Rapamycin Activity is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors

Cap-independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α-estradiol

Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence

Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

In vivo reprogramming of leads to heterogeneous effects on lifespan

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Rapamycin preserves gut homeostasis during Drosophila aging

Rapamycin increased inducible efficiency of iPSCs through activating autophagy

A small-molecule approach towards the Fountain of Youth: chemically induced pluripotent stem cells

Mtor Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

Molecular Insights into the Heterogeneity of Telomere Reprogramming in Induced Pluripotent Stem Cells

Reducing Sphingolipid Synthesis Orchestrates Global Changes To Extend Yeast Lifespan

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse nematodes

Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming

Dissecting Somatic Cell Reprogramming by MicroRNAs and Small Molecules: A Dissertation

The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging